Quantification of Utilization Management Barriers for Patients Initiating Therapy to Lower Lipid Levels

This cohort study quantifies the rejections that patients with new-to-class claims face when attempting to initiate therapy with PCSK9 inhibitors and explores the association of rejection with subsequent behavior.

Saved in:
Bibliographic Details
Published inJAMA network open Vol. 5; no. 11; p. e2240513
Main Authors O'Neil, Adam, Calderbank, Steve, Brown, James, Vandigo, Joe, Yin, Perry, Bratti, Keith, Howell, Scott
Format Journal Article
LanguageEnglish
Published United States American Medical Association 01.11.2022
Subjects
Health Policy
Humans
Lipids
Online Only
PCSK9 Inhibitors
Research Letter
Retrospective Studies
Online AccessGet full text

Cover

More Information
Summary:This cohort study quantifies the rejections that patients with new-to-class claims face when attempting to initiate therapy with PCSK9 inhibitors and explores the association of rejection with subsequent behavior.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2574-3805
2574-3805
DOI:10.1001/jamanetworkopen.2022.40513